Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

272 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies.
Heurling K, Ashton NJ, Leuzy A, Zimmer ER, Blennow K, Zetterberg H, Eriksson J, Lubberink M, Schöll M. Heurling K, et al. Among authors: scholl m. Mol Cell Neurosci. 2019 Jun;97:34-42. doi: 10.1016/j.mcn.2019.02.001. Epub 2019 Feb 20. Mol Cell Neurosci. 2019. PMID: 30796959 Free article. Review.
Biomarkers for microglial activation in Alzheimer's disease.
Lautner R, Mattsson N, Schöll M, Augutis K, Blennow K, Olsson B, Zetterberg H. Lautner R, et al. Among authors: scholl m. Int J Alzheimers Dis. 2011;2011:939426. doi: 10.4061/2011/939426. Epub 2011 Nov 1. Int J Alzheimers Dis. 2011. PMID: 22114747 Free PMC article.
Amyloid biomarkers in Alzheimer's disease.
Blennow K, Mattsson N, Schöll M, Hansson O, Zetterberg H. Blennow K, et al. Among authors: scholl m. Trends Pharmacol Sci. 2015 May;36(5):297-309. doi: 10.1016/j.tips.2015.03.002. Epub 2015 Apr 1. Trends Pharmacol Sci. 2015. PMID: 25840462 Review.
18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
Mattsson N, Schöll M, Strandberg O, Smith R, Palmqvist S, Insel PS, Hägerström D, Ohlsson T, Zetterberg H, Jögi J, Blennow K, Hansson O. Mattsson N, et al. Among authors: scholl m. EMBO Mol Med. 2017 Sep;9(9):1212-1223. doi: 10.15252/emmm.201707809. EMBO Mol Med. 2017. PMID: 28743782 Free PMC article.
Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.
Mattsson N, Smith R, Strandberg O, Palmqvist S, Schöll M, Insel PS, Hägerström D, Ohlsson T, Zetterberg H, Blennow K, Jögi J, Hansson O. Mattsson N, et al. Among authors: scholl m. Neurology. 2018 Jan 30;90(5):e388-e395. doi: 10.1212/WNL.0000000000004887. Epub 2018 Jan 10. Neurology. 2018. PMID: 29321235 Free PMC article.
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.
Thordardottir S, Rodriguez-Vieitez E, Almkvist O, Ferreira D, Saint-Aubert L, Kinhult-Ståhlbom A, Thonberg H, Schöll M, Westman E, Wall A, Eriksdotter M, Zetterberg H, Blennow K, Nordberg A, Graff C. Thordardottir S, et al. Among authors: scholl m. Alzheimers Res Ther. 2018 May 10;10(1):45. doi: 10.1186/s13195-018-0374-y. Alzheimers Res Ther. 2018. PMID: 29747683 Free PMC article.
Update on biomarkers for amyloid pathology in Alzheimer's disease.
Ashton NJ, Schöll M, Heurling K, Gkanatsiou E, Portelius E, Höglund K, Brinkmalm G, Hye A, Blennow K, Zetterberg H. Ashton NJ, et al. Among authors: scholl m. Biomark Med. 2018 Jul;12(7):799-812. doi: 10.2217/bmm-2017-0433. Epub 2018 Jun 15. Biomark Med. 2018. PMID: 29902934 Review.
272 results